Navigation Links
Vampire bats keep out of trouble by running

Although most people think of bats as stealthy mammals that flit about in the night sky, at least one species has evolved a terrestrial trot never before seen in bats, according to a recent Cornell University study.

It's known that the common vampire bats of Central and South America behave much more like four-legged terrestrial mammals, in that they like to walk around on the ground; other bat species fumble helplessly when left to walk. But researchers in Cornell's College of Veterinary Medicine have discovered that these bats not only walk but run. The unprecedented gait of Desmodus rotundus is described in a brief communication in this week's issue of Nature magazine (March 17, 2005) from Daniel Riskin, Cornell graduate student in zoology, and his adviser John W. Hermanson, associate professor of biomedical sciences.

What seemed like a crazy idea -- challenging these bats on an increasingly speedy treadmill -- revealed a novel ability which the researchers believe evolved independently to facilitate feeding behavior. "What we observed was like a horse going from a walk to a gallop over a very short amount of time," Riskin explains. The researchers kept increasing the speed of the treadmill and, much to their surprise, their subjects broke into a run.

"They just seem to do everything a little differently from the general bat rule," Riskin says about what he refers to as the "cute, adorable, big-eyed and family-oriented" vampire bats.

Not only are vampire bats unusual because they run, but also in the way that they power their gait. "Unlike most animals which use their hind legs as a source of power, these exceptional creatures power their run with their forelimbs," Hermanson explains. Getting most of the push from their long forelimbs -- actually their wings and therefore very strong -- the bats run more like a small gorilla than a comparable four-legged creature like a mouse. They run up to about 2.5 miles per hour. Although many o
'"/>

Source:Cornell University News Service


Page: 1 2

Related biology news :

1. Vampire bats recognise their preys breathing
2. New research indicates a troubled greenhouse is brewing
3. Double trouble: Cells with duplicate genomes can trigger tumors
4. Fast test for low blood flow in dogs detects early heart trouble

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vampire bats keep out trouble running

(Date:11/25/2009)...may be used to boost resistance to, or slow, the d...Medicine researchers report in a study published i... , Parkinson,s disease is caused by a degenerati...known as the substantia nigra, which is responsibl...dopamine in late-stage Parkinson,s causes symptoms...
(Date:11/25/2009)...ps some 250 million liters of blood through the bo...the heart have to be extremely durable. The resear...air of the Department of Medicine III at Heidelber...atus), has discovered a protein that is responsibl... the sarcomere. In cooperation with other research...
(Date:11/24/2009)...standing how sounds associated with Navy sonar mig...ey hear it at all. , The same type of large indu...ct flaws in the space shuttle,s behemoth solid fue...e the giant head of a whale. The scans are providi...s hearing anatomy using a breakthrough method deve...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 1Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 2Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 3Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 4Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 5Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 1Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 2Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 3Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 4Study reveals 2 3 of prostate cancer patients do not need treatment 58130 1Study reveals 2 3 of prostate cancer patients do not need treatment 58130 2
...out of the Ireland Cancer Center of University Hos... majority of triple negative breast cancers expres..., presented today at the San Antonio Breast Cancer...ine trial for patients with early stage triple neg... recurrence of this aggressive type of breast canc...
...lable in Spanish . , , The conditioning Works o...amount of vegetable species. The researchers of th...aged to grow in the laboratory two native bushy sp...able cover restoration. They will try to use them ... of Sierra Nevada . , The vegetable species of Si...
...ilable in French . , A novel x-ray technique al...me scale never reached before has been developed b...errer Institute (PSI) in Switzerland. Results of t...f EPFL,s laboratory of Ultrafast Spectroscopy in c...line December 11 in the journal Science . , This...
Other Biology News:Ireland Cancer Center researcher finds most triple-negative breast cancers express muc-1 target 2An essay proves that vegetation could recover in the ski resort of Sierra Nevada 2Molecules in the spotlight 2
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in ...w consistent growth during the U.S. recession. How...ouble, and health systems are coming closer to hav...just administrators. , (V...continued growing in October despite the shedding ...
(Date:11/24/2009)...PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chin...edthe,investigationalnewdrugapplication(IND)forits...mulationtotreatdiabetes.ThisIND,approvalallowsBiol...iabetesisadisordercharacteristicofhighbloodglucose...resultinseveremicro-and,macro-vasculardiseases,los...
(Date:11/24/2009)...,, TORONTO,Nov.24/PRNewswire-FirstCall/-Hamilto...aleadingproviderofadvancedlasersystemsandinstrumen...todayreportedoperationalandfinancialresultsforthet...ghts,-Revenuewas$1.46millioncomparedwith$1.43mill...edwith66.1percentinQ3,2008,-Netlossreducedto$148,0...
(Date:11/24/2009)...mber24/PRNewswire/--HealthRoboticstodayannounced,t...selected,investors.ThisrecentlyformedToronto-based...a,Inc.andwillmarket,install,andsupport,HealthRobot...volutionaryproductofferingsi.v.STATION(TM),i.v.SOF...provideassistanceonan"asneeded,basis"toitsstrategi...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...ts for the Product,TopoTarget Successfully Buys Ba... the Global Rights for the Product ... Corporation, COPENHAGEN, April 22 , - Deal Cove..., a Total,of 5 Million TopoTarget Shares and a Com...all to be Held 2pm CET, TopoTarget A/S (OMX: TOPO...
...Ortho Evra is an adhesive,transdermal birth contro...lgestromin and 20 mcg of ethinyl estradiol into th...week for three weeks, and no patch is worn,during ...A in November,2001, and over 4 million women have ...tinues to be marketed aggressively to both consume...
.../PRNewswire-FirstCall/-- Pharmacyclics,Inc. (Nasda...aq staff,deficiency letter on April 17, 2008 indic...bid price for Pharmacyclics, common stock has clos...1.00 per share for continued,inclusion on The Nasd.... In,accordance with Marketplace Rule 4450(e)(2), ...
Other Biology Technology:TopoTarget Successfully Buys Back Full Control of Belinostat 2TopoTarget Successfully Buys Back Full Control of Belinostat 3TopoTarget Successfully Buys Back Full Control of Belinostat 4TopoTarget Successfully Buys Back Full Control of Belinostat 5TopoTarget Successfully Buys Back Full Control of Belinostat 6TopoTarget Successfully Buys Back Full Control of Belinostat 7Ortho Evra Patch Makers Settling Cases 2
Rabbit Anti-Histamine H2 Receptor Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
Mouse Anti-Human GLP Monoclonal Antibody, Unconjugated, Clone 1B7B4 from ProMab Biotechnologies, Inc.
GIBCO Sf-900 Medium (1.3X) liquid from Invitrogen
Biology Products: